Diabetes Care Devices Market size is projected to expand at 10% CAGR from 2024 to 2032, led by the rising prevalence of diabetes globally, owing to sedentary lifestyles and unhealthy dietary habits. According to the CDC, total 38.4 million people in the U.S. have diabetes. Rising technological developments are promoting the development of more efficient and user-friendly devices for improving patient compliance and adoption.

The growing awareness about the importance of regular monitoring and management of blood glucose levels among diabetic patients will escalate the demand for the devices. The implementation of favorable reimbursement policies for diabetes care in many regions and the growing geriatric population prone to diabetes-related complications will also complement the industry progression.
The diabetes care devices market is segregated into product, end-use, and region.

In terms of product, the market value from the insulin delivery devices segment will rise at 10.2% growth rate until 2032. Innovations in technology are resulting in the development of more user-friendly and convenient insulin delivery devices. The increasing prevalence of diabetes globally, coupled with the rising adoption of insulin therapy are accelerating the appeal of insulin delivery devices. The jump in initiatives to enhance patient adherence to insulin therapy will also amplify the product adoption.

Diabetes care devices industry share from the homecare end-use segment is estimated to witness 10.4% CAGR between 2024 and 2032. This can be credited to the increasing preference for home-based management of diabetes due to the convenience and comfort provided by these devices to homecare patients. Growing technology improvements are encouraging development of compact and easy-to-use devices suitable for home settings, further boosting the product adoption in homecare settings.

Regionally, the Europe diabetes care devices industry size is anticipated to expand at 9.7% growth rate until 2032, on account of the increasing awareness about diabetes management, rising prevalence of diabetes, and the rollout of supportive government initiatives. The development of innovative glucose monitoring systems and insulin delivery devices are enhancing the effectiveness and convenience of diabetes management solutions for patients across the region.